What is Semax?
Semax is a synthetic peptide developed in Russia, where it has been studied and used in certain clinical settings. It is researched for cognitive performance and neuroprotection.
Western clinical data is limited. It is not FDA-approved and is among the peptides under the 2026 compounding review.
How it is thought to work
Semax has been studied for influence on brain-derived growth factors and attention-related pathways, which underlies interest in cognitive applications.
What the research shows
As with Selank, much of the research is small-scale or outside large Western trials, so the evidence base is early-stage.
We summarize published research and do not make therapeutic promises. A licensed provider can evaluate whether any therapy is appropriate for you. Treat any source promising guaranteed results with skepticism.
Studied uses
- Focus and cognitive-performance research
- Neuroprotection studies
- Recovery from mental fatigue (reported)
Legal status in 2026
Semax is not FDA-approved and is among the peptides under federal review in 2026. No rule has changed yet, and it would remain prescription-only even if reclassified.
How to access Semax legitimately
A licensed provider can review whether it is appropriate and, where permitted, prescribe through a licensed compounding pharmacy.
PeptideForward can match you with vetted telehealth providers who handle these therapies through legitimate channels. The eligibility check takes about five minutes and there is no cost to see if you are a candidate.
Frequently asked questions
Is Semax proven to improve cognition? Evidence is early-stage and largely from outside large Western trials. A provider can give a realistic view.
Is it legal now? It is not approved. Where permitted it requires a prescription, and its compounding status is under 2026 review.
Does PeptideForward sell it? No. We connect you with licensed providers only.